Source: Eur Respir J 2016; 47: 553-563
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ventetuolo Corey E., Mitra Nandita, Wan Fei, Manichaikul Ani, Barr R. Graham, Johnson Craig, Bluemke David A., Lima Joao A.C., Tandri Hari, Ouyang Pamela, Kawut Steven M.. Oestradiol metabolism and androgen receptor genotypes are associated with right ventricular function. Eur Respir J 2016; 47: 553-563

Member's Comments

No comment yet.

Related content which might interest you: Adrenergic receptor blocker reverses cardiac metabolic remodeling and improves right ventricular function in experimental pulmonary hypertension Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease Year: 2011 Plasma VEGF correlates with right ventricular function in pulmonary hypertension Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Estrogen receptor alpha gene polymorphisms and primary pulmonary hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 352s Year: 2005 Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females Source: Eur Respir J 2009; 34: 1093-1099 Year: 2009 Growth hormone releasing hormone receptor (GHRH-R) antagonist MIA-602 modulates fibrosis and gene expression in lungs of bleomycin-treated mice Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 Roles of sex hormones on bone morphogenetic protein signaling in pulmonary artery differed between testosterone and estrogen Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Glucocorticoid-induced adrenal suppression and metabolic syndrome in glucocorticoid treated AECOPD patients related to different gene polymorphisms of the glucocorticoid receptor gene Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020 Epigenetic modulation of right ventricular failure Source: International Congress 2016 – Pulmonary arterial hypertension: future therapeutic approaches Year: 2016 Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects Source: Eur Respir J, 50 (2) 1602337; 10.1183/13993003.02337-2016 Year: 2017 Serum levels of circulating FAS/APO-1 in patients with isolated left- and right ventricular dysfunction Source: Eur Respir J 2004; 24: Suppl. 48, 561s Year: 2004 No associations of the mineralocorticoid and glucocorticoid receptor genes with asthma Source: Eur Respir J 2012; 40: 1572-1574 Year: 2012 The effect of androgen replacement treatment on pulmonary functions in male patients with hypogonadism Source: Eur Respir J 2006; 28: Suppl. 50, 862s Year: 2006 Sex differences in the relation between sex hormones and right ventricular function in pulmonary arterial hypertension Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension Year: 2020 The effect of estrogen and its receptor on hypoxic pulmonary vascular remodeling Source: Eur Respir J 2006; 28: Suppl. 50, 658s Year: 2006 Expression of estrogen receptors and estrogen metabolism genes in lungs of COPD patients Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015 Association of adrenal response in asthmatic children on inhaled steroids with polymorphisms in the genes of glucocorticoid receptor (GR) and corticotropin releasing hormone receptor 1 (CRHR1) Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009 The hsp90 inhibitor, 17-AAG prevents and reverses the increases in lung calcineurin expression and activity associated with monocrotaline-induced right ventricular hypertrophy Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Dehydroepiandrosterone reverses chronic hypoxia/reoxygenation-induced right ventricular dysfunction in rats Source: Eur Respir J 2012; 40: 1420-1429 Year: 2012 Growth hormone-releasing hormone receptor antagonist MIA-602 modulates mouse lung inflammation and fibrosis due to bleomycin Source: International Congress 2018 – New insights in the signalling pathways that underlie IPF pathophysiology Year: 2018 Endocrinological derangements in COPD Source: Eur Respir J 2009; 34: 975-996 Year: 2009